Reported rates of all-cause serious adverse events following immunization with BNT-162b in 5–17-year-old children in the United States

Vaccine development against COVID-19 has mitigated severe disease. However, reports of rare but serious adverse events following immunization (sAEFI) in the young populations are fuelling parental anxiety and vaccine hesitancy. With a very early season of viral illnesses including COVID-19, respirat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangat, Halinder S., Rippon, Brady, Reddy, Nikita T., Syed, Akheel A., Maruthanal, Joel M., Luedtke, Susanne, Puthumana, Jyothy J., Srivatsa, Abhinash, Bosman, Arnold, Kostkova, Patty
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937486/
https://www.ncbi.nlm.nih.gov/pubmed/36800368
http://dx.doi.org/10.1371/journal.pone.0281993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937486/
https://www.ncbi.nlm.nih.gov/pubmed/36800368
http://dx.doi.org/10.1371/journal.pone.0281993

Ejemplares similares